Illumina Passes Antitrust Hurdle to Acquire Solexa | GenomeWeb
NEW YORK (GenomeWeb News) — Illumina today said it has received clearance under Hart-Scott-Rodino Antitrust regulations to continue with its proposed acquisition of Solexa.
 
The companies yesterday said Solexa and Illumina shareholders will vote on aspects of the acquisition on Jan. 26, 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.